However, the Albumin To prevenT Infection in chronic liveR failurE (ATTIRE) trial showed no effect of targeted albumin infusions that achieved a serum albumin ≥30 g/L to hospitalised patients for development of infection, renal dysfunction ,or mortality compared with standard care.25 The gene discussed is ALB; the disease is Abnormal renal physiology.